News
Interview in Next Generation Pharmaceutical |
| 08-12-2008 |
NGP gathers industry experts of Cisbio, MILabs, PerkinElmer and Roche to discuss the current drug development space. Prof. Beekman, CEO/CSO Milabs states that drug development can, and needs to become, much faster and effective by using novel tools that facilitate early selection of potentially successful drug leads.
Back